Bronchitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD
Conditions:   COVID-19;   Chronic Bronchitis;   COPD Intervention:   Biological: Inactivated COVID-19 vaccine Sponsors:   China National Biotec Group Company Limited;   Zhejiang Provincial Center for Disease Control and Prevention;   Beijing Institute of Biological Products Co Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2021 Category: Research Source Type: clinical trials